Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219914 · ClinicalTrials.gov registry record · NA
This Study Explores the Mental Health Impact of Two Akashic Records Sessions.
A NA study of Depression and Anxiety, sponsored by Rasa Healing.
- Active
- Registry status
- NA
- Development phase
- 117
- Enrollment target
- 1
- Study location
NCT07219914: Active NA study of Depression and Anxiety, sponsored by Rasa Healing.
NCT07219914 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by Rasa Healing. The registered enrollment target is 117 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07219914, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by Rasa Healing.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 117 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity). Main questions this study will answer are: After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life? What participants will do: Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later. Surveys include: DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words. Who can take part: Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year. How the research will happen: Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis. Risks and benefits: Talking
Primary Outcome
Change in participant self-reported depression, anxiety, and stress symptoms as measured by the DASS-21 (Depression, Anxiety, Stress Scale - 21 items). The DASS-21 has three subscales (Depression, Anxiety, Stress), each ranging from 0-42. Higher scores indicate greater symptom severity. Scores are calculated by summing responses (0 = "did not apply to me at all" to 3 = "applied very much/most of the time") and multiplying by two for comparability with the original 42-item scale. Analysis will co
Conditions Studied
Interventions
- BEHAVIORAL Akashic Records Session
Study Locations (1)
Florida
- Virtual/ No Physical Facility - Palm City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2024-06-21 |
| Est. Completion | 2026-01-22 |
| Phase | NA |
What the registry record for NCT07219914 still lists
NCT07219914 is an interventional study that assigns participants to a tested intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Akashic Records Session is the first listed.
NCT07219914 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07219914 about?
NCT07219914 is a clinical study titled "This Study Explores the Mental Health Impact of Two Akashic Records Sessions.". The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and hum...
What is the current status of trial NCT07219914?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 117 participants. The study started on 2024-06-21. Estimated completion is 2026-01-22.
What conditions does trial NCT07219914 study?
This clinical trial studies the following conditions: Depression, Anxiety, Stress, Resilience, Connectedness.
What interventions are being tested in trial NCT07219914?
The interventions under investigation include: Akashic Records Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219914?
This trial is sponsored by Rasa Healing, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219914 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07219914's enrollment target sits among peer trials
117 305th of 679 higher than 374 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy